1. Home
  2. OGN vs RXRX Comparison

OGN vs RXRX Comparison

Compare OGN & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.66

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Recursion Pharmaceuticals Inc.

RXRX

Recursion Pharmaceuticals Inc.

HOLD

Current Price

$3.24

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
RXRX
Founded
1923
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
OGN
RXRX
Price
$13.66
$3.24
Analyst Decision
Hold
Buy
Analyst Count
5
4
Target Price
$11.40
$7.50
AVG Volume (30 Days)
3.1M
15.1M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
0.60%
N/A
EPS Growth
N/A
14.79
EPS
0.95
N/A
Revenue
$6,216,000,000.00
$74,681,000.00
Revenue This Year
$0.45
$12.11
Revenue Next Year
$1.67
$82.52
P/E Ratio
$14.36
N/A
Revenue Growth
N/A
26.92
52 Week Low
$5.69
$2.77
52 Week High
$13.79
$7.18

Technical Indicators

Market Signals
Indicator
OGN
RXRX
Relative Strength Index (RSI) 43.71 52.71
Support Level $13.46 $2.87
Resistance Level $13.79 $3.42
Average True Range (ATR) 0.03 0.18
MACD -0.02 -0.02
Stochastic Oscillator 12.90 51.67

Price Performance

Historical Comparison
OGN
RXRX

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Share on Social Networks: